NCT06156501 is a NA clinical trial of ACL Reconstruction in ACL Tear, sponsored by Medical University of Vienna.

Who is sponsoring NCT06156501?

NCT06156501 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT06156501?

Interventions in NCT06156501: ACL Reconstruction.

Is NCT06156501 still recruiting?

NCT06156501 is currently status unknown. Last updated 5 December 2023.

Last reviewed 2023-12-05 · How we verify

NCT06156501

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychological Factors Influencing the Patient-reported and Functional Outcome of ACL Reconstruction and Their Sex-specific Differences

Status unknown NA Last updated 5 December 2023

What this trial tests

NA trial testing ACL Reconstruction in ACL Tear in 100 participants. Status unknown.

Timeline

1 August 2023

Primary endpoint
1 January 2025

1 June 2025

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 August 2023
Primary completion	1 January 2025
Estimated completion	1 June 2025
Sites	1 location across Austria

Drugs / interventions tested

ACL Reconstruction

Conditions studied

ACL Tear — all drugs for ACL Tear →

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with ACL Tear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Psychological parameters among patients undergoing ACL reconstruction and their impact on the patient-reported and functional outcome of reconstruction will be prospectively evaluated

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ACL Reconstruction

Trials testing the same drug.

NCT07418476 — Comparison of Standard ACL Reconstruction Versus TARS-Augmented Reconstruction · NA · recruiting
NCT06289153 — Internal Bracing Following ACL Reconstruction · NA · withdrawn
NCT04039971 — Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial · NA · active not recruiting
NCT03441295 — LIBRE (Ligamys, Internal Bracing, REconstruction) Study: Comparing Three Surgery Techniques After an Acute ACL Rupture. · NA · active not recruiting

Other recruiting trials for ACL Tear

Currently open trials in the same condition.

NCT06486246 — Geniculate Nerve Block Versus Adductor Canal Block for ACL Reconstruction Surgery · NA · recruiting
NCT06235736 — Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle? · recruiting
NCT05735236 — Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation · NA · recruiting
NCT05338385 — Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study · NA · active not recruiting
NCT04536103 — Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06156501 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 5 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06156501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing